Ocular Therapeutix, Inc (OCUL)

Last Three Months

20-Jan-19 -- 19-Apr-19

Time Period:

Three Months
|
Year

$385.49K Net Amount

Buy:	$385.49K	$4.15 - $4.33
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

13

0

0

+1

1

+2

2

+3

Two Year Chart

20-Apr-17 -- 19-Apr-19

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
14-Mar-19 4:14 PM View:	13-Mar-19 Market Purchase $244.39K	Lindstrom Richard L Md Director		Ocular Therapeutix, Inc - OCUL	130% 43.56K to 100.0K	$244.39K 130%	0	$4.33	--	Show Txns Hide Txns

18-Mar-19 6:20 PM View:	15-Mar-19 Market Purchase $99.60K	Heier Jeffrey S. Director		Ocular Therapeutix, Inc - OCUL	100% 0 to 24.0K	$99.60K 100%	0	$4.15	--	Show Txns Hide Txns

18-Mar-19 6:20 PM View:	15-Mar-19 Market Purchase $41.50K	Goldstein Michael H. Chief Medical Officer		Ocular Therapeutix, Inc - OCUL	271% 3.69K to 13.69K	$41.50K 271%	0	$4.15	--	Show Txns Hide Txns